Cover Image

Beneficial Effect of Dimethyl Fumarate Drug Repositioning in a Mouse Model of TDP-43-Dependent Frontotemporal Dementia

Frontotemporal dementia (FTD) causes progressive neurodegeneration in the frontal and temporal lobes, leading to behavioral, cognitive, and language impairments. With no effective treatment available, exploring new therapeutic approaches is critical. Recent research highlights the transcription fact...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ignacio Silva-Llanes (Author), Raquel Martín-Baquero (Author), Alicia Berrojo-Armisen (Author), Carmen Rodríguez-Cueto (Author), Javier Fernández-Ruiz (Author), Eva De Lago (Author), Isabel Lastres-Becker (Author)
Format:	Book
Published:	MDPI AG, 2024-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Transcriptional targets of amyotrophic lateral sclerosis/frontotemporal dementia protein TDP-43 - meta-analysis and interactive graphical database
by: Maize C. Cao, et al.
Published: (2022)

Progranulin Deficiency Induces Mitochondrial Dysfunction in Frontotemporal Lobar Degeneration with TDP-43 Inclusions
by: Guiomar Rodríguez-Periñán, et al.
Published: (2023)

Endogenous progesterone levels and frontotemporal dementia: modulation of TDP-43 and Tau levels in vitro and treatment of the A315T TARDBP mouse model
by: Theresa N. T. Dang, et al.
Published: (2013)

TDP-43 mislocalization drives neurofilament changes in a novel model of TDP-43 proteinopathy
by: Rachel Atkinson, et al.
Published: (2021)

Frontotemporal Dementia: A Clinical Review
by: Michał Dacka, et al.
Published: (2024)

Quantitative analysis of cryptic splicing associated with TDP-43 depletion
by: Jack Humphrey, et al.
Published: (2017)

Drug-Repurposing Strategy for Dimethyl Fumarate
by: Salvatore Giunta, et al.
Published: (2023)

Metal Toxicity and Dementia Including Frontotemporal Dementia: Current State of Knowledge
by: Francesca Gorini, et al.
Published: (2024)

Dimethyl fumarate for treating Papillon-Lefèvre syndrome
by: Abdullah Al-Omair, MD, et al.
Published: (2023)

The Advance on Frontotemporal Dementia (FTD)'s Neuropathology and Molecular Genetics
by: Jindong Wang, et al.
Published: (2022)

TDP-43 promotes tau accumulation and selective neurotoxicity in bigenic Caenorhabditis elegans
by: Caitlin S. Latimer, et al.
Published: (2022)

Prevention of Autoimmune Diabetes in NOD Mice by Dimethyl Fumarate
by: Shiri Li, et al.
Published: (2021)

Therapeutic Potential of Polyphenols in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
by: Valentina Novak, et al.
Published: (2021)

Frontotemporal dementia in amyotrophic lateral sclerosis: from rarity to reality?
by: Marco Orsini, et al.
Published: (2016)

Vitamin B12 Reduces TDP-43 Toxicity by Alleviating Oxidative Stress and Mitochondrial Dysfunction
by: Yu-Mi Jeon, et al.
Published: (2021)

HEXA-018, a Novel Inducer of Autophagy, Rescues TDP-43 Toxicity in Neuronal Cells
by: Shinrye Lee, et al.
Published: (2021)

Dimethyl Fumarate Induces Metabolic Crisie to Suppress Pancreatic Carcinoma
by: Kaiyuan Chen, et al.
Published: (2021)

Dimethyl fumarate ameliorates chemotherapy agent-induced neurotoxicity in vitro
by: Takehiro Kawashiri, et al.
Published: (2018)

Novel potential pharmacological applications of dimethyl fumarate-an overview and update
by: Giorgia Bresciani, et al.
Published: (2023)

Therapeutic Effects of Dimethyl Fumarate on the Rat Model of Brain Ischemia
by: Maryam Owjfard, et al.
Published: (2022)

Physiological tissue-specific and age-related reduction of mouse TDP-43 levels is regulated by epigenetic modifications
by: Miriam Pacetti, et al.
Published: (2022)

Dimethyl Fumarate as Therapeutic Alternative in Moderate-to-Severe Psoriasis: Our Experience
by: Rosés Gibert P, et al.
Published: (2022)

Exploring the Use of Dimethyl Fumarate as Microglia Modulator for Neurodegenerative Diseases Treatment
by: Maria Rosito, et al.
Published: (2020)

Dimethyl fumarate titration for the systemic treatment of moderate-to-severe plaque psoriasis
by: Giovanna Malara, et al.
Published: (2021)

Dimethyl Fumarate and Its Esters: A Drug with Broad Clinical Utility?
by: Stephanie Kourakis, et al.
Published: (2020)

Sleep-related breathing disorder (central sleep apnoea) improved coincidentally by medical therapy with fumarates (dimethyl fumarate)
by: Abdulmajeed M Albadi, et al.
Published: (2023)

Successful management of bullous pemphigoid with dimethyl fumarate therapy: A case report
by: Aslı Bilgic-Temel, MD, et al.
Published: (2019)

Dimethyl fumarate as a safe and effective therapy for recalcitrant psoriasis in comorbid patients
by: Martina Burlando, et al.
Published: (2021)

Dimethyl Fumarate Ameliorates Doxorubicin-Induced Cardiotoxicity By Activating the Nrf2 Pathway
by: Xiaoliang Hu, et al.
Published: (2022)

Anti-Inflammatory Effects of Dimethyl Fumarate in Microglia via an Autophagy Dependent Pathway
by: Young-Sun Lee, et al.
Published: (2021)

Dimethyl fumarate in the management of multiple sclerosis: appropriate patient selection and special considerations
by: Prosperini L, et al.
Published: (2016)

Calming the (Cytokine) Storm: Dimethyl Fumarate as a Therapeutic Candidate for COVID-19
by: Cara A. Timpani, et al.
Published: (2020)

Sustained therapeutic benefits by transient reduction of TDP-43 using ENA-modified antisense oligonucleotides in ALS/FTD mice
by: Toshihide Takeuchi, et al.
Published: (2023)

Amyotrophic lateral sclerosis mutant TDP-43 may cause synaptic dysfunction through altered dendritic spine function
by: Tongcui Jiang, et al.
Published: (2019)

Influence of Inflammatory Cytokines IL-1β and IFNγ on Sarcoplasmic Aggregation of p62 and TDP-43 in Myotubes
by: Bryony McCord, et al.
Published: (2023)

A Sensitization-Free Dimethyl Fumarate Prodrug, Isosorbide Di-(Methyl Fumarate), Provides a Topical Treatment Candidate for Psoriasis
by: Krzysztof Bojanowski, et al.
Published: (2021)

Dignity in people with frontotemporal dementia and similar disorders - a qualitative study of the perspective of family caregivers
by: Mette Sagbakken, et al.
Published: (2017)

Glucose-Impaired Corneal Re-Epithelialization Is Promoted by a Novel Derivate of Dimethyl Fumarate
by: Giovanni Giurdanella, et al.
Published: (2021)

Antioxidant and Anti-inflammatory Effect of Nrf2 Inducer Dimethyl Fumarate in Neurodegenerative Diseases
by: Sarah A. Scuderi, et al.
Published: (2020)

Design of oral agents for the management of multiple sclerosis: benefit and risk assessment for dimethyl fumarate
by: Nicholas JA, et al.
Published: (2014)